Indian Journal of Transplantation (Jan 2021)

Clinical characteristics and outcome of novel coronavirus disease in kidney transplant recipients: A single-center prospective observational study

  • Venkatesh Arumugam,
  • Bhagavatula V. R. H. Sastry,
  • Dolphin J Solomon,
  • Natarajan Gopalakrishnan,
  • Badri Srinivasan Kannan,
  • P Shankar,
  • N Sheik Sulthan Alavudeen,
  • Shivakumar Dakshinamoorthy,
  • Malathy Natarajan

DOI
https://doi.org/10.4103/ijot.ijot_137_20
Journal volume & issue
Vol. 15, no. 3
pp. 189 – 198

Abstract

Read online

Background: Organ transplant recipients are at increased risk of infections which may result in acute graft dysfunction and death. Coronavirus disease (COVID-19) is the ongoing global infectious challenge and little is known about the impact of this novel virus in kidney transplant recipients. We here describe the clinical presentations, laboratory profile, and outcomes of 42 such patients, from a large tertiary care center in south India. Materials and Methods: This prospective, observational study included all renal transplant recipients with confirmed COVID-19 by reverse transcription polymerase chain reaction from the start of the outbreak till August, 2020. Clinical features at presentation, laboratory and radiological data, and outcomes were analyzed. Results: Forty-two patients were included in the analysis. As many as, 86.7% patients of our cohort had symptoms at presentation, with the most common symptoms being fever (52.5%), breathlessness (50%), and cough (40.5%). Significant need for respiratory support was noted in individuals with longer duration posttransplant (P < 0.03). Acute worsening of allograft function was observed in 22 (52.4%) patients. Fourteen (65%) of them had acute on chronic graft dysfunction and acute graft dysfunction was noted in 8 (35%) patients. Six patients (14.5%) died due to the disease and none of the parameters were found to be an independent predictor of mortality in regression analytic models including acute graft dysfunction (P = 0.49) or acute on chronic graft dysfunction (P = 0.07). There was no correlation between disease severity and baseline immunosuppressive agents whether tacrolimus or cyclosporine (P = 0.57) and mycophenolate mofetil or azathioprine (P = 0.91). Conclusions: Our largest cohort of patients from India showed higher incidence of acute graft dysfunction and significant mortality in patients with COVID-19.

Keywords